Bayer resumes efforts to sell diabetes device unit: sources

November 25, 2014 8:03 AM

3 0

Bayer resumes efforts to sell diabetes device unit: sources

FRANKFURT (Reuters) - German drugmaker Bayer AG is considering a fresh attempt to sell its diabetes device business as it sharpens its focus on margin-rich healthcare sectors, two people familiar with the matter told Reuters on Tuesday.

Bayer is overhauling its structure with plans to list its plastics business on the stock market to free up money for investments and acquisitions in healthcare, veterinary drugs and crop protection products.

Also read: PAI Partners expects bids for French lab business Cerba on Decemeber 8: sources

Read more

To category page

Loading...